Literature DB >> 12688357

Primary anaplastic large cell lymphoma of the kidney.

Ioannis D Venizelos1, Vasilios Rombis, Stavros Tulupidis, Vasiliki Garipidou.   

Abstract

Primary renal lymphoma is a rare disease. There is still no agreement on its development primarily in this non-lymphoid organ. Some of the reported cases are questionable because of the incomplete staging of extrarenal disease. In the present study, we describe a rare case of a 73-year-old white man presenting with right flank pain. Physical examination did not reveal any peripheral lymphadenopathy or hepatosplenomegaly. An abdominal computerized tomography (CT) showed a large tumor in the right kidney with no enlarged liver, spleen or lymph nodes. On morphological and immunohistochemical examination, the tumor fulfilled the criteria of anaplastic large cell lymphoma (ALCL). A review of the literature revealed that this is the first reported case of primary ALCL of the kidney.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12688357     DOI: 10.1080/1042819021000030027

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Unusual presentation of anaplastic large cell lymphoma with clinical course mimicking fever of unknown origin and sepsis: autopsy study of five cases.

Authors:  Marina B Mosunjac; J Bruce Sundstrom; Mario I Mosunjac
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

2.  PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement.

Authors:  Doen Ming Ong; Katherine D Cummins; Alan Pham; George Grigoriadis
Journal:  BMJ Case Rep       Date:  2015-07-17

3.  Renal involvement of lymphomas proven by kidney biopsy: report of 10 cases from a tertiary care center and comparison with the literature.

Authors:  Fanny Urbain; Sophie Ferlicot; Laurence Rocher; Florent L Besson; Léa Gomez; Jean-Marie Michot; Thierry Lazure; Xavier Mariette; Gaëtane Nocturne; Olivier Lambotte; Mohamad Zaidan; Nicolas Noel
Journal:  Int J Hematol       Date:  2022-07-13       Impact factor: 2.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.